BioRem Inc. (TSXV:BRM)
Canada · Delayed Price · Currency is CAD | Market Cap | 61.14M +83.0% |
| Revenue (ttm) | 50.70M +32.2% |
| Net Income | 6.22M +97.7% |
| EPS | 0.34 +107.1% |
| Shares Out | 16.22M |
| PE Ratio | 11.20 |
| Forward PE | 9.79 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 40,408 |
| Open | 3.780 |
| Previous Close | 3.770 |
| Day's Range | 3.750 - 3.890 |
| 52-Week Range | 1.870 - 3.890 |
| Beta | 0.85 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 25, 2026 |
About BioRem
BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. The company offers biofilters; biotrickling filters; multi-stage systems; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. It also sells biofiltration media products under the BIOSORBENS, XLD, BIOPAK, BIOROLL, and BIOBLOK names. The company operates in Canada, the United States... [Read more]
Financial Performance
In 2025, BioRem's revenue was 42.36 million, an increase of 13.19% compared to the previous year's 37.42 million. Earnings were 4.82 million, an increase of 58.25%.
Financial StatementsNews
BioRem Registration statement: Q2 2026
BioRem filed a registration statement on July 28, 2026, providing details about a securities offering with the SEC.
BioRem Registration statement: Q2 2026
BioRem filed a registration statement on July 28, 2026, providing details about a securities offering with the SEC.
BioRem Earnings release: Q2 2026
BioRem released its Q2 2026 earnings on July 28, 2026, summarizing the period's financial results.
BioRem Registration statement: Q1 2026
BioRem filed a registration statement on May 14, 2026, providing details about a securities offering with the SEC.
BioRem Registration statement: Q1 2026
BioRem filed a registration statement on May 14, 2026, providing details about a securities offering with the SEC.
BioRem Earnings release: Q1 2026
BioRem released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
BioRem Registration statement: Q4 2025
BioRem filed a registration statement on April 20, 2026, providing details about a securities offering with the SEC.
BioRem Registration statement: Q4 2025
BioRem filed a registration statement on April 20, 2026, providing details about a securities offering with the SEC.
BioRem Earnings release: Q4 2025
BioRem released its Q4 2025 earnings on April 20, 2026, summarizing the period's financial results.
BioRem Registration statement: Q3 2025
BioRem filed a registration statement on November 16, 2025, providing details about a securities offering with the SEC.
BioRem Registration statement: Q3 2025
BioRem filed a registration statement on November 16, 2025, providing details about a securities offering with the SEC.
BioRem Earnings release: Q3 2025
BioRem released its Q3 2025 earnings on November 16, 2025, summarizing the period's financial results.
BioRem Transcript: Planet MicroCap Showcase: TORONTO 2025
Management reduced outstanding shares by 60% through a strategic buyback, strengthening capital structure. The business is experiencing strong organic growth, driven by new products and services, with a record backlog and expanding service revenue. Market demand is supported by infrastructure upgrades, regulatory trends, and a disciplined M&A approach.
BioRem Earnings release: Q2 2025
BioRem released its Q2 2025 earnings on August 25, 2025, summarizing the period's financial results.
BioRem Registration statement: Q2 2025
BioRem filed a registration statement on August 25, 2025, providing details about a securities offering with the SEC.
BioRem Registration statement: Q2 2025
BioRem filed a registration statement on August 25, 2025, providing details about a securities offering with the SEC.
BIOREM Reports Strong First Quarter Financial Results and Continued Growth in Order Backlog
GUELPH, ON , May 28, 2024 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced results for the three month period ended March 31, 2024. BIOREM's complete 2024 first quart...